Effectiveness and Feasibility of Interventions for Weight Management of Young Adults in Low- and Middle-Income Countries (LMICs): A Systematic Review With Meta-Analysis.

Obes RevJul 13, 2026 (epub)
Clinical ResearchPreventive Medicine / Public HealthInternal Medicine (General)EndocrinologyOpen access

Sujata Shakya, Subas Neupane, Shanti Bajracharya et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and meta-analysis evaluated the effectiveness of weight management interventions for young adults in low- and middle-income countries (LMICs). Among the nine studies analyzed, interventions resulted in a significant reduction in mean BMI (-1.13 kg/m²) and waist circumference (-1.66 cm) compared to controls. The quality of evidence was moderate.

Key findings

  • Mean BMI decreased by -1.13 kg/m² in the intervention group compared to controls.
  • Waist circumference reduced by -1.66 cm in the intervention group versus controls.
  • Greater effects were noted in interventions lasting 6 months or longer.
  • No studies reported on the feasibility of the interventions.

Why it matters

Understanding the effectiveness of weight management interventions in LMICs is crucial as obesity rates rise among young adults, posing significant health risks. This evidence can inform future public health strategies and resource allocation.

Source

PubMed · PMID 42444264Free full text on PubMed Central

Published in Obes Rev. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Preventive Medicine / Public Health

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary
Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.